Melatech

Denmark · owned by Independent (Denmark) · melatech.io · 10 vendors

Melatech is a Danish company that empowers primary care clinicians with an AI-enhanced hardware and software platform. The platform enables clinicians to capture clinical data, collaborate with specialists, and convert consultations into structured documentation. Its goal is to reduce administrative burden and free up more time for direct patient care.

Resilience scores

Technology vendors

Insights

Last updated 2026-09-13 · revision 2

10 direct vendors, 164 subvendors

Direct vendors by controlling owner country (sample)

Subvendors by controlling owner country (sample)

Migration Readiness: 1/10

Assessed by AI based on technology stack characteristics (cloud-native vs legacy, containerization, microservices), regulatory environment, data residency requirements, financial stability, and vendor lock-in risks. The score ranges from 0-10, where higher scores indicate better readiness for technology migration.

**Score: 1.0 (Confidence Level: N/A - No data available)** This score of 1.0 is assigned due to the complete absence of verified information regarding melatech.io's internal tech stack, architecture, and cloud adoption. Without access to official sources or real-time web browsing capabilities, it is impossible to assess their migration readiness against criteria such as cloud-nativeness, containerization, microservices adoption, or vendor lock-in. Therefore, this score does not reflect an actual assessment of the company's readiness but rather indicates that no data was available to perform such an assessment.

Compliance

7 in-scope frameworks identified; showing 3.

EU AI Act (source) — Assessment Required

Melatech explicitly states it provides an "AI-enhanced Hardware and Software Platform" for healthcare. AI systems used in medical devices are typically classified as high-risk under the EU AI Act, subjecting them to stringent requirements before being placed on the market.

If Melatech's AI system is classified as high-risk, non-compliance could lead to fines up to €35 million or 7% of global turnover. Medical device AI is often high-risk, and failure to comply would block market access, halting business operations.

Evidence: https://trust.melatech.io/, https://www.pharmalex.com/thought-leadership/blogs/what-global-ai-regulations-mean-for-medical-device-manufacturers/, https://www.mddionline.com/artificial-intelligence/eu-ai-act-compliance-what-companies-need-to-know-about-penalties, https://www.activemind.legal/guides/ai-act/, https://blog.sendsafely.com/understanding-the-eu-ai-act, https://www.beneschlaw.com/insight/european-union-artificial-intelligence-act-an-overview/

SOC 2 (source) — Assessment Required

Melatech offers a SaaS platform and is active in the USA. US customers, particularly in healthcare, frequently require their service providers to furnish a SOC 2 report to demonstrate that adequate controls are in place to protect their data.

Similar to ISO 27001, a SOC 2 report is often required by customers, especially in the US market, to provide assurance over the security, availability, and confidentiality of the services provided. Absence of a report can be a barrier to sales.

Evidence: https://thehub.io/startups/melatech, https://trust.melatech.io/, https://medstack.co/blog/what-medstacks-soc-2-report-means-for-you/, https://www.neumetric.com/service/soc-2-report/

NIS2 (source) — Assessment Required

Melatech operates in the healthcare sector, which is listed as an 'Essential Entity' under Annex I of the NIS2 Directive. The company has 11-50 employees, meeting the 'medium-sized' threshold. Danish implementing law covers manufacturers of medical devices.

Non-compliance for an Essential Entity can result in fines up to €10 million or 2% of global turnover. As a healthcare entity, a cybersecurity incident could severely impact patient safety and data integrity, attracting maximum regulatory scrutiny.

Evidence: https://nis2-compliant.com/industries/healthcare, https://nis2directive.eu/health/, https://thehub.io/startups/melatech, https://lifesciencelaw.dk/events/webinar-on-nis2-the-danish-implementation-and-regulatory-supervision/, https://trust.melatech.io/

Financials

Three-year financials

Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.

View the full interactive report